Voacristine

Details

Top
Internal ID 93b5b1c3-fdd2-4d30-9a4d-9e933bdd2f61
Taxonomy Alkaloids and derivatives > Ibogan-type alkaloids
IUPAC Name methyl (1S,15R,17S,18S)-17-[(1S)-1-hydroxyethyl]-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-1-carboxylate
SMILES (Canonical) CC(C1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC)C(=O)OC)O
SMILES (Isomeric) C[C@@H]([C@H]1C[C@@H]2C[C@@]3([C@H]1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC)C(=O)OC)O
InChI InChI=1S/C22H28N2O4/c1-12(25)16-8-13-10-22(21(26)28-3)19-15(6-7-24(11-13)20(16)22)17-9-14(27-2)4-5-18(17)23-19/h4-5,9,12-13,16,20,23,25H,6-8,10-11H2,1-3H3/t12-,13+,16+,20-,22+/m0/s1
InChI Key OYMQKBZMKFJPMH-VJMPXSKLSA-N
Popularity 6 references in papers

Physical and Chemical Properties

Top
Molecular Formula C22H28N2O4
Molecular Weight 384.50 g/mol
Exact Mass 384.20490738 g/mol
Topological Polar Surface Area (TPSA) 74.80 Ų
XlogP 2.40
Atomic LogP (AlogP) 2.23
H-Bond Acceptor 5
H-Bond Donor 2
Rotatable Bonds 3

Synonyms

Top
545-84-6
Voacangarine
(?)-Voacangarine
methyl (1S,15R,17S,18S)-17-[(1S)-1-hydroxyethyl]-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-1-carboxylate
NSC 306219
Ibogamine-18-carboxylic acid, 20-hydroxy-12-methoxy-, methyl ester, (20S)-

2D Structure

Top
2D Structure of Voacristine

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8766 87.66%
Caco-2 + 0.7148 71.48%
Blood Brain Barrier + 0.6000 60.00%
Human oral bioavailability - 0.6714 67.14%
Subcellular localzation Mitochondria 0.5507 55.07%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9204 92.04%
OATP1B3 inhibitior + 0.9102 91.02%
MATE1 inhibitior - 0.8800 88.00%
OCT2 inhibitior - 0.7500 75.00%
BSEP inhibitior + 0.8455 84.55%
P-glycoprotein inhibitior - 0.4368 43.68%
P-glycoprotein substrate + 0.8081 80.81%
CYP3A4 substrate + 0.6618 66.18%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate + 0.4651 46.51%
CYP3A4 inhibition - 0.5867 58.67%
CYP2C9 inhibition - 0.8452 84.52%
CYP2C19 inhibition - 0.8438 84.38%
CYP2D6 inhibition - 0.6424 64.24%
CYP1A2 inhibition - 0.7834 78.34%
CYP2C8 inhibition - 0.8018 80.18%
CYP inhibitory promiscuity - 0.7701 77.01%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.6563 65.63%
Eye corrosion - 0.9906 99.06%
Eye irritation - 0.9895 98.95%
Skin irritation - 0.7936 79.36%
Skin corrosion - 0.9487 94.87%
Ames mutagenesis - 0.7400 74.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7193 71.93%
Micronuclear + 0.6200 62.00%
Hepatotoxicity - 0.5500 55.00%
skin sensitisation - 0.8781 87.81%
Respiratory toxicity + 0.8889 88.89%
Reproductive toxicity + 0.9444 94.44%
Mitochondrial toxicity + 0.9875 98.75%
Nephrotoxicity - 0.9282 92.82%
Acute Oral Toxicity (c) III 0.4470 44.70%
Estrogen receptor binding + 0.7891 78.91%
Androgen receptor binding + 0.6732 67.32%
Thyroid receptor binding + 0.5951 59.51%
Glucocorticoid receptor binding + 0.7862 78.62%
Aromatase binding + 0.7079 70.79%
PPAR gamma - 0.5391 53.91%
Honey bee toxicity - 0.7922 79.22%
Biodegradation - 0.9500 95.00%
Crustacea aquatic toxicity - 0.6700 67.00%
Fish aquatic toxicity + 0.9087 90.87%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.53% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 99.48% 96.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 99.14% 94.45%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 98.59% 85.14%
CHEMBL2535 P11166 Glucose transporter 96.88% 98.75%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 94.14% 95.56%
CHEMBL2581 P07339 Cathepsin D 94.05% 98.95%
CHEMBL4208 P20618 Proteasome component C5 93.78% 90.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 91.95% 97.09%
CHEMBL205 P00918 Carbonic anhydrase II 91.36% 98.44%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 89.64% 96.77%
CHEMBL340 P08684 Cytochrome P450 3A4 89.10% 91.19%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 88.99% 90.71%
CHEMBL1821 P08173 Muscarinic acetylcholine receptor M4 88.99% 94.08%
CHEMBL5608 Q16288 NT-3 growth factor receptor 88.98% 95.89%
CHEMBL255 P29275 Adenosine A2b receptor 88.24% 98.59%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 85.20% 95.89%
CHEMBL3437 Q16853 Amine oxidase, copper containing 85.13% 94.00%
CHEMBL3430907 Q96GD4 Aurora kinase B/Inner centromere protein 85.06% 97.50%
CHEMBL4073 P09237 Matrix metalloproteinase 7 84.84% 97.56%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 83.42% 92.62%
CHEMBL2782 P35610 Acyl coenzyme A:cholesterol acyltransferase 1 83.38% 91.65%
CHEMBL4302 P08183 P-glycoprotein 1 83.36% 92.98%
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 83.10% 86.92%
CHEMBL5469 Q14289 Protein tyrosine kinase 2 beta 82.95% 91.03%

Cross-Links

Top
PubChem 196982
LOTUS LTS0092040
wikiData Q104252751